Healthcare News

Elion will present new turletricin clinical data at IDWeek 2026, including three Phase 1 studies and a Phase 2 cryptococcal meningitis study.

BOSTON, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its...

Opus Genetics Announces FDA Clearance of IND Application for OPGx-RDH12 Gene Therapy for Inherited Childhood Blindness

BASEL, Switzerland and LONDON and NEW YORK, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Monday,...

ELLON, Scotland and LONDON, Oct. 21, 2026 (GLOBE NEWSWIRE) -- BrewDog, a leader in U.K. craft beer and one of the world’s most recognised beer brands, owned by Tilray Brands, Inc. (NASDAQ: TLRY;...

Initial focus on named-patient access in selected European and MENA markets, providing a capital-efficient foundation for broader commercialization BOCA RATON, Fla., Oct. 21, 2026 (GLOBE NEWSWIRE)...

—Expands BioCryst portfolio of targeted oral prophylactic therapy options to meet patients’ individual needs and preferences—  —ORLADEYO is the first and only targeted oral prophylactic therapy with...

Entrada Therapeutics announces the appointment of Linea Aspesi as Chief People Officer.

WuXi AppTec outlines five 2026 peptide manufacturing trends as oral dosing, which can need 10 to 100 times the API, shifts pressure into purification.

Our longstanding collaboration with the government is grounded in a shared goal of expanding the tools available to protect and treat from deadly diseases